Nomura Holdings’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,048
Closed -$565K 1349
2022
Q2
$565K Buy
10,048
+6,281
+167% +$353K ﹤0.01% 733
2022
Q1
$275K Sell
3,767
-37,983
-91% -$2.77M ﹤0.01% 1033
2021
Q4
$4.06M Buy
41,750
+33,334
+396% +$3.24M 0.01% 464
2021
Q3
$710K Buy
8,416
+2,405
+40% +$203K ﹤0.01% 897
2021
Q2
$494K Sell
6,011
-32,461
-84% -$2.67M ﹤0.01% 994
2021
Q1
$3.67M Buy
38,472
+24,393
+173% +$2.33M 0.01% 436
2020
Q4
$873K Sell
14,079
-9,966
-41% -$618K ﹤0.01% 716
2020
Q3
$1.43M Buy
24,045
+18,915
+369% +$1.12M ﹤0.01% 461
2020
Q2
$358K Sell
5,130
-4,408
-46% -$308K ﹤0.01% 658
2020
Q1
$430K Buy
+9,538
New +$430K ﹤0.01% 413
2019
Q4
Sell
-12,035
Closed -$733K 825
2019
Q3
$733K Buy
12,035
+12
+0.1% +$731 ﹤0.01% 534
2019
Q2
$861K Sell
12,023
-24,045
-67% -$1.72M ﹤0.01% 531
2019
Q1
$2.8M Sell
36,068
-16,831
-32% -$1.3M 0.01% 354
2018
Q4
$4.46M Buy
52,899
+44,400
+522% +$3.75M 0.02% 321
2018
Q3
$1.45M Buy
8,499
+484
+6% +$82.3K 0.01% 497
2018
Q2
$1.04M Buy
+8,015
New +$1.04M ﹤0.01% 532
2015
Q2
Sell
-6,874
Closed -$326K 1523
2015
Q1
$326K Sell
6,874
-1,651
-19% -$78.3K ﹤0.01% 933
2014
Q4
$288K Sell
8,525
-10,110
-54% -$342K ﹤0.01% 1173
2014
Q3
$573K Buy
18,635
+1,478
+9% +$45.4K ﹤0.01% 960
2014
Q2
$670K Buy
17,157
+2,504
+17% +$97.8K ﹤0.01% 932
2014
Q1
$612K Buy
14,653
+8,238
+128% +$344K ﹤0.01% 1059
2013
Q4
$211K Buy
+6,415
New +$211K ﹤0.01% 1629
2013
Q3
Sell
-21,222
Closed -$497K 2382
2013
Q2
$497K Buy
+21,222
New +$497K ﹤0.01% 1242